News | May 10, 2009

Medtronic, Johnson and Johnson Reach Agreement on Royalty Disputes

May 10, 2009 - Medtronic Inc. Friday announced the settlement of all royalty disputes with Johnson and Johnson (J&J) that concern Medtronic’s licensed use of the Palmaz, Schatz and Pinchuk patents relating to coronary angioplasty stent design and balloon material patents.

The agreement ends all current and potential disputes between the two parties under their 1997 settlement and license agreement. Other disputes between the parties are unaffected by this settlement, Medtronic said.

“Resolving these disputes allows us to focus our resources on the development of new products that will improve the quality of care for people with cardiovascular disease,” said Scott Ward, president of the CardioVascular business and senior vice president at Medtronic.

Medtronic paid J&J $270 million for all alleged royalty claims against its products under a 1997 settlement and license agreement between the parties. Medtronic will reflect the settlement as a one-time charge in its fourth fiscal quarter, ending in April 2009.

For more information: www.medtronic.com

Related Content

Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter| November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter| March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter| January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter| October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init